Adenosylhomocysteinase (AHCY) Antibody

Este producto es parte de AHCY - Adenosylhomocysteinase (Like)
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Adenosylhomocysteinase (AHCY) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx109497
tested applications
ELISA, IHC, IF/ICC

Description

AHCY Antibody is a Rabbit Polyclonal antibody against AHCY.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Adenosylhomocysteinase (AHCY)
Host
Rabbit
Reactivity
Human
Recommended Dilution
IHC: 1/20 - 1/200, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P23526
Gene ID
191
NCBI Accession
NP_000678.1, NM_000687.3
OMIM
180960
Alias
SAHH,adoHcyase
Background
Antibody anti-AHCY
Status
RUO

Descripción

AHCY, also known as S-adenosylhomocysteine hydrolase, is a critical enzyme in the methionine cycle that catalyzes the reversible hydrolysis of S-adenosylhomocysteine (SAH) into homocysteine and adenosine. This reaction is essential for maintaining cellular methylation reactions, as SAH is a potent inhibitor of methyltransferases. AHCY is ubiquitously expressed and localized in the cytoplasm and nucleus, where it regulates methylation-dependent processes such as DNA and histone modification, gene expression, and cell signaling. Dysregulation of AHCY leads to the accumulation of SAH, disrupting methylation and contributing to diseases such as homocystinuria, cardiovascular disease, and neurodegenerative disorders. Mutations in the AHCY gene can cause autosomal recessive hypermethioninemia. AHCY is also being studied as a potential target in cancer and metabolic disorders due to its pivotal role in methylation homeostasis.

Related Products

EH1440

Human AHCY(Adenosylhomocysteinase) ELISA Kit

Ver Producto
EM0560

Mouse Ahcy(Adenosylhomocysteinase) ELISA Kit

Ver Producto
FNab00226

anti- AHCY antibody

Adenosylhomocysteine is a competitive inhibitor of S-adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylations via regulation of the intracellular concentration of adenosylhomocysteine.

Ver Producto